Profil
Dr. Seid is a molecular biologist who is currently Technical Manager for the Molecular Genomics BioProduction group at the American Type Culture Collection (Manassas Virginia), where he is responsible for directing the manufacture of ATCC's Molecular Genomics products and managing the automated robotic processes.
Prior to this, we was the chief Protein Scientist for Regeneration Technologies, Inc. (RTI), where his primary focus was the identification of factors in human tissue that could enhance the healing capabilities of allograft implants.
At RTI, he was part of a team that received a 3-year NIST-ATP award to develop an allograft-based gene delivery method.
Before his work with RTI, he was involved in the cloning, expression, optimization and manufacture of recombinant proteins for use in clinical trials program at Zonagen, Inc., a reproductive healthcare/biopharmaceutical company based in The Woodlands, Texas.
He has also worked at M.D.
Anderson Cancer Center (Houston, Texas) in the Department of Cell Biology, where he focused on mechanisms of multi-drug resistance and the efficacy of Biological Response Modifiers as adjunct therapy for treatment of cancer.
Dr. Seid received his Ph.D.
in Molecular and Developmental Biology from the University of Houston in 1994, and his BS in Microbiology from Stephen F.
Austin State University (Nacogdoches Texas) in 1987.
Anciens postes connus de Chris Seid
| Sociétés | Poste | Fin |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Regeneration Technologies, Inc.
 Regeneration Technologies, Inc. Medical SpecialtiesHealth Technology Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL. | Corporate Officer/Principal | - |
Formation de Chris Seid
| University of Houston | Doctorate Degree |
| Stephen F. Austin State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Regeneration Technologies, Inc.
Regeneration Technologies, Inc. Medical SpecialtiesHealth Technology Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |